Showing results (191-200 of 245) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|September 6, 2013
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational studyRoxana Mehran, Usman Baber, Philippe Gabriel Steg, et al.
Circulation. Cardiovascular Interventions|March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS RegistrySabato Sorrentino, Samantha Sartori, Usman Baber, et al.
Journal of the American College of Cardiology|September 7, 2014
A polypill strategy to improve adherence: results from the FOCUS projectJosé M Castellano, Ginés Sanz, José L Peñalvo, et al.
The New England Journal of Medicine|November 1, 2013
Bivalirudin started during emergency transport for primary PCIPhilippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, et al.
Journal of the American College of Cardiology|April 3, 2020
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary InterventionDominick J Angiolillo, Usman Baber, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 24, 2018
The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
The American Journal of Cardiology|October 2, 2018
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)Sabato Sorrentino, Gennaro Giustino, Usman Baber, et al.
Journal of the American College of Cardiology|July 5, 2023
P2Y<sub>12</sub> Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary EventsFelice Gragnano, Davide Cao, Leah Pirondini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2023
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trialAlessandro Spirito, Adnan Kastrati, Davide Cao, et al.
International Journal of Cardiology|November 5, 2018
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary interventionMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Pageof 25